RxDoctor Payments Data

Jorge Guttin

Interventional Cardiology · Houston, TXNPI 1497730337

Payments from drug & device makers

$2,615in general payments, 2019–2025

Across 159 payments — averaging $16.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$548
  • Amarin Pharma, Inc.$295
  • Novo Nordisk$215
  • Kowa Pharmaceuticals America, Inc.$214
  • Novartis$198
  • Amgen$176
  • plus $970 from 19 others

What the payments were for

  • Food & beverage$2,615100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,615 in reported general payments places this provider in the 10th percentile of 686 interventional cardiology providers in Texas.

See all interventional cardiology providers in Texas

Other interventional cardiology in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →